![]() |
|
|
Forward to a colleague |
||
Product Overview ![]() Pharmatest offers unique preclinical in vitro and in vivo drug efficacy testing services to pharmaceutical companies developing new drugs against osteoporosis, cancer or osteoarthritis. Our services can also be used for testing existing compounds for possible adverse effects on bone or secondary indication for bone-related diseases, as well as development of functional foods for bone health... Click Here Access Full Stories Newron Pharmaceuticals and its partner Merck KGaA suffered a disappointment yesterday, when their investigational Parkinson's disease drug failed a pivotal clinical trial... Read Pfizer expands biologics R&D Pfizer is breaking ground on a $50m expansion of its biologics pilot plant in Chesterfield, at a time when the drug giant is cutting back in other business areas... Read Amgen expounds IL-17 potential as arthritis target Amgen are rushing to discover how interleukin-17 causes inflammation and bone destruction in rheumatoid arthritis, as it could provide a valuable new therapeutic target... Read Novartis turns its back on India Novartis is to pull millions of planned investment dollars out of India in reaction to intellectual property (IP) fears. The decision may leave China as the cat that got the cream... Read Drugs moving into the clinic: 25 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read |
||||||||||||||
All News Headlines for: August | July | June |
||||||||||||||
|
deltaDOT label free analysis of biomolecules Faster, higher quality results at a fraction of the cost of conventional approaches. Analyse & Quantify Antibodies, Proteins and Small molecules - with high resolution, sensitivity & reproducibility... Click Here |
||||||||||||||
|
Related Industry News FDA embraces outsourcing The US Food and Drug Administration (FDA) is following the growing pharma industry trend by embracing outsourcing as part of a cost-saving drive - a move that is attracting strong opposition... Read Pharma packaging goes futuristic A France-based packaging solutions company plans to launch heat-shrink labels with integrated holograms into the pharma industry, in what it believes will be the next big counterfeiting solution for the sector... Read GPC feeling the pressure Just weeks after disappointing news regarding its potential billion-dollar drug satraplatin was swiftly followed by a class action lawsuit against the company, GPC Biotech has announced plans to cut 15 per cent... Read Symyx expands lab automation tools Symyx Technologies has released a machine designed to automate the sample preparation stage of active pharmaceutical ingredient (API) solubility experiments, saving researchers valuable time... Read
|
||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||